Search results for "Pharmaceutical Research"

Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the Ministry of Food and Drug Safety for...
SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs

SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs

SK Plasma announced on Sept. 1 that it has begun distributing Revolpag Tablets 75 mg in South Korea, expanding its lineup following the August...
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
Dongkook Pharmaceutical Launches PDRN-Infused Lightweight Moisturizer

Dongkook Pharmaceutical Launches PDRN-Infused Lightweight Moisturizer

Dongkook Pharmaceutical has expanded its skincare portfolio with a new moisturizing cream that incorporates...
Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports

Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports

GLP-1 (glucagon-like peptide-1) class medications, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, are...
South Korea Bans Pharmacies From Using 'Warehouse' or 'Factory' on Signage

South Korea Bans Pharmacies From Using 'Warehouse' or 'Factory' on Signage

Pharmacies in South Korea will no longer be allowed to use terms that evoke a “warehouse” or “factory” on their...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
Even Seoul-Area Tertiary Hospitals Fall Into the Red as 253 Institutions Record a Nine-Year Financial Slide

Even Seoul-Area Tertiary Hospitals Fall Into the Red as 253 Institutions Record a Nine-Year Financial Slide

It is a familiar refrain in the healthcare industry that managing hospital finances has grown exceptionally difficult.
Yuhan Expands Antiphlamine Initiative into Nationwide Veterans Support Pact Ahead of 100th Anniversary

Yuhan Expands Antiphlamine Initiative into Nationwide Veterans Support Pact Ahead of 100th Anniversary

Nine years into the program, the cumulative total of the "Patriotism Antiphlamine Sharing Box" delivered by Yuhan...
Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars

Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars

Celltrion is consolidating its leading market position across major Asian countries with its key autoimmune and...